Janssen Therapeutics, a division of
New Brunswick, N.J.-based pharmaceutical company Johnson & Johnson,
announced they will provide up to $30,000 in grants and/or charitable donations
to 16 organizations, four of which are in the New York metropolitan area.
The funding will increase awareness
and provide treatment to HIV-positive individuals. Janssen will use their
three-year-old pilot program, Linking in Need Communities to Care (LINCC), to
make the donations. Through LINCC, Janssen has donated more than $1.6 million
to service organizations across the nation since 2010.
The Friends of AIDS Foundation is
dedicated to enhancing the quality of life for HIV positive individuals and
empowering people to make healthy choices to prevent the spread of the HIV
virus. To learn more about The Friends of AIDS Foundation, please visit: http://www.friendsofaids.org.
TOGETHER WE REMAIN STRONG!